Ruste V, Goldschmidt V, Laparra A, Messayke S, et al. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry. Eur J Cancer 2021;158:217-224.
PMID: 34627664